Avellino Labs is a global leader in gene therapy and molecular diagnostics, and the pioneer in personalized medicine for eye care. Avellino Labs is pioneering CRISPR gene editing to manage and potentially cure inherited diseases. Avellino Labs continues to expand its diagnostics capabilities, building on the success of the world's first DNA test to confirm the presence of genetic indicators that are positively associated with corneal dystrophies, providing life-changing information for patient treatment decisions and follow up care. Avellino Labs is headquartered in Silicon Valley, California, with operations in Korea, Japan, China and the UK.

Biotechnology

Avellino Labs

Thomas Kim

Nancy Selph

Scott Korney

Cyril Allouche

Horiuchi Nobuhide

Prabal Chatterjee

Jason Junghan Kim

Genya Dana

John Hong

Eric Bernabei

Avellino Labs' Founding Team includes Gene Lee.

Founding Team

Board of Directors

Leadership Team

CEO and Executive Team

Founding Team

About

Team members

Other teams at Avellino Labs

Board of Directors

Leadership Team

CEO and Executive Team